• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Raymond H. Mak, MD

Publications

  • Parikh RB, Cronin AM, Kozono DE, Oxnard GR, Mak RH, Jackman DM, Lo PC, Baldini EH, Johnson BE, Chen AB.Definitive Primary Therapy in Patients Presenting With Oligometastatic Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys. 2014 May 24.
    24867533
  • Coroller TP, Mak RH, Lewis JH, Baldini EH, Chen AB, Colson YL, Hacker FL, Hermann G, Kozono D, Mannarino E, Molodowitch C, Wee JO, Sher DJ, Killoran JH.Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry.PLoS ONE. 2014;9(4):e94859.
    24728448
  • Velazquez ER, Parmar C, Jermoumi M, Mak RH, van Baardwijk A, Fennessy FM, Lewis JH, De Ruysscher D, Kikinis R, Lambin P, Aerts HJ.Volumetric CT-based segmentation of NSCLC using 3D-Slicer.Sci Rep. 2013;3:3529.
    24346241
  • Williams CL, Mishra P, Seco J, St James S, Mak RH, Berbeco RI, Lewis JH.A mass-conserving 4D XCAT phantom for dose calculation and accumulation.Med Phys. 2013 Jul;40(7):071728.
    23822432
  • Mishra P, Li R, James SS, Mak RH, Williams CL, Yue Y, Berbeco RI, Lewis JH.Evaluation of 3D fluoroscopic image generation from a single planar treatment image on patient data with a modified XCAT phantom.Phys Med Biol. 2013 Feb 21;58(4):841-58.
    23337614
  • Mak RH, Doran E, Muzikansky A, Kang J, Neal JW, Baldini EH, Choi NC, Willers H, Jackman DM, Sequist LV.Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC.Oncologist. 2011;16(6):886-95.
    21632451
  • Mak RH, Digumarthy SR, Muzikansky A, Engelman JA, Shepard JA, Choi NC, Sequist LV.Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer.Oncologist. 2011;16(3):319-26.
    21339258
  • Novershtern N, Subramanian A, Lawton LN, Mak RH, Haining WN, McConkey ME, Habib N, Yosef N, Chang CY, Shay T, Frampton GM, Drake AC, Leskov I, Nilsson B, Preffer F, Dombkowski D, Evans JW, Liefeld T, Smutko JS, Chen J, Friedman N, Young RA, Golub TR, Regev A, Ebert BL.Densely interconnected transcriptional circuits control cell states in human hematopoiesis.Cell. 2011 Jan 21;144(2):296-309.
    21241896
  • Mak RH, Halasz LM, Tanaka CK, Ancukiewicz M, Schultz DJ, Russell AH, Viswanathan AN.Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3-4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva.Gynecol Oncol. 2011 Jan;120(1):101-7.
    20950845
  • Mak RH, McCarthy EP, Das P, Hong TS, Mamon HJ, Hoffman KE.Adoption of Preoperative Radiation Therapy for Rectal Cancer From 2000 to 2006: A Surveillance, Epidemiology, and End Results Patterns-of-Care Study.Int J Radiat Oncol Biol Phys. 2010 Oct 18.
    20961695
  • Mak KS, Lee LK, Mak RH, Wang S, Pile-Spellman J, Abrahm JL, Prigerson HG, Balboni TA.Incidence and Treatment Patterns in Hospitalizations for Malignant Spinal Cord Compression in the United States, 1998-2006.Int J Radiat Oncol Biol Phys. 2010 Jul 12.
    20630663
  • Bradner JE, Mak R, Tanguturi SK, Mazitschek R, Haggarty SJ, Ross K, Chang CY, Bosco J, West N, Morse E, Lin K, Shen JP, Kwiatkowski NP, Gheldof N, Dekker J, DeAngelo DJ, Carr SA, Schreiber SL, Golub TR, Ebert BL.Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease.Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12617-22.
    20616024
  • Mak RH,Zietman AL,Heney NM,Kaufman DS,Shipley WU.Bladder preservation: optimizing radiotherapy and integrated treatment strategies.BJU Int. 2008 Nov;102(9 Pt B):1345-53. Review.
    19035903
  • Haining WN, Ebert BL, Subrmanian A, Wherry EJ, Eichbaum Q, Evans JW, Mak R, Rivoli S, Pretz J, Angelosanto J, Smutko JS, Walker BD, Kaech SM, Ahmed R, Nadler LM, Golub TR.Identification of an evolutionarily conserved transcriptional signature of CD8 memory differentiation that is shared by T and B cells.J Immunol. 2008 Aug 1;181(3):1859-68.
    18641323
  • Lu J, Guo S, Ebert BL, Zhang H, Peng X, Bosco J, Pretz J, Schlanger R, Wang JY, Mak RH, Dombkowski DM, Preffer FI, Scadden DT, Golub TR.MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.Dev Cell. 2008 Jun;14(6):843-53.
    18539114
  • Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR.MicroRNA expression profiles classify human cancers.Nature. 2005 Jun 9;435(7043):834-8.
    15944708